Clinical Trials Directory

Trials / Sponsors / Galectin Therapeutics Inc.

Galectin Therapeutics Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
TerminatedStudy Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrho
Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis
Phase 2 / Phase 32020-06-25
CompletedA Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Func
Hepatic Impairment
Phase 12020-06-16
CompletedAn Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis
Psoriasis
Phase 22015-09-01
CompletedClinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Adv
Nonalcoholic Steatohepatitis
Phase 22015-09-01
CompletedClinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resul
Hypertension, Portal
Phase 22015-06-01
CompletedPhase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advance
Non-Alcoholic Steatohepatitis (NASH)
Phase 12013-07-01
WithdrawnA New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
Colorectal Cancer
Phase 22006-10-01
WithdrawnStudy to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder
Cancer of the Bile Duct, Gallbladder Cancer
Phase 22006-09-01
TerminatedGM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer
Colorectal Cancer
Phase 22005-05-01
CompletedSafety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors
Colorectal Cancer, Lung Cancer, Breast Cancer
Phase 12003-02-01